Pratiks Multani News Today

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2023 earnings estimates for shares of ORIC Pharmaceuticals in a note issued to investors on Monday, February 26th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will post earnings per share of ($1.90) for the year. Cantor Fitzgerald has […]

Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $10.12, but opened at $10.43. ORIC Pharmaceuticals shares last traded at $10.52, with a volume of 36,713 shares. Analyst Ratings Changes A number of research analysts have weighed in on […]

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have covered the stock in the last […]

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $12.03 and last traded at $11.92, with a volume of 71670 shares traded. The stock had previously closed at $11.48. Wall Street Analyst Weigh In ORIC has been the […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $10.02, but opened at $10.63. ORIC Pharmaceuticals shares last traded at $10.60, with a volume of 85,540 shares. Analyst Upgrades and Downgrades Several equities analysts recently issued reports on ORIC […]

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “outperform” rating reaffirmed by stock analysts at Wedbush in a research note issued on Monday, RTT News reports. They presently have a $12.00 price objective on the stock. Wedbush’s price objective would indicate a potential upside of 42.52% from the stock’s current price. Separately, HC […]

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been given a consensus recommendation of “Buy” by the seven research firms that are presently covering the company, Marketbeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have updated their coverage on the stock […]

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) insider Pratik S. Multani sold 5,282 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $8.59, for a total value of $45,372.38. Following the completion of the sale, the insider now directly owns 23,809 shares […]